Imagion Biosystems Statistics

Total Valuation

ASX:IBX has a market cap or net worth of AUD 12.26 million. The enterprise value is 14.68 million.

Market Cap	12.26M
Enterprise Value	14.68M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:IBX has 490.59 million shares outstanding. The number of shares has increased by 295.60% in one year.

Current Share Class	490.59M
Shares Outstanding	490.59M
Shares Change (YoY)	+295.60%
Shares Change (QoQ)	+251.56%
Owned by Insiders (%)	6.63%
Owned by Institutions (%)	1.29%
Float	424.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.62
PB Ratio	-3.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.67
EV / Sales	13.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.19

Current Ratio	0.19
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.80

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-83.89%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	25.26%
Weighted Average Cost of Capital (WACC)	8.81%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.45
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.89% in the last 52 weeks. The beta is -0.16, so ASX:IBX's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	+38.89%
50-Day Moving Average	0.02
200-Day Moving Average	0.02
Relative Strength Index (RSI)	49.38
Average Volume (20 Days)	2,191,916

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:IBX had revenue of AUD 1.06 million and -2.20 million in losses. Loss per share was -0.02.

Revenue	1.06M
Gross Profit	376,043
Operating Income	-976,561
Pretax Income	-2.20M
Net Income	-2.20M
EBITDA	-1.31M
EBIT	-976,561
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 883,565 in cash and 3.30 million in debt, with a net cash position of -2.42 million or -0.00 per share.

Cash & Cash Equivalents	883,565
Total Debt	3.30M
Net Cash	-2.42M
Net Cash Per Share	-0.00
Equity (Book Value)	-3.87M
Book Value Per Share	-0.02
Working Capital	-3.88M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.89M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 35.62%, with operating and profit margins of -92.49% and -208.52%.

Gross Margin	35.62%
Operating Margin	-92.49%
Pretax Margin	-208.52%
Profit Margin	-208.52%
EBITDA Margin	-123.97%
EBIT Margin	-92.49%
FCF Margin	n/a

Dividends & Yields

ASX:IBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-295.60%
Shareholder Yield	-295.60%
Earnings Yield	-17.95%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 16, 2023. It was a reverse split with a ratio of 0.025.

Last Split Date	Nov 16, 2023
Split Type	Reverse
Split Ratio	0.025

Scores

ASX:IBX has an Altman Z-Score of -110.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-110.11
Piotroski F-Score	1